{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T18:19:39Z","timestamp":1767896379231,"version":"3.49.0"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1007\/s10157-008-0078-x","type":"journal-article","created":{"date-parts":[[2008,8,27]],"date-time":"2008-08-27T03:04:13Z","timestamp":1219806253000},"page":"85-88","source":"Crossref","is-referenced-by-count":19,"title":["Massive proteinuria and acute renal failure after oral bisphosphonate (alendronate) administration in a patient with focal segmental glomerulosclerosis"],"prefix":"10.1007","volume":"13","author":[{"given":"Naoto","family":"Miura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natsuko","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuhei","family":"Aoyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wataru","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harutaka","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Imai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,2,1]]},"reference":[{"issue":"Suppl 12","key":"78_CR1","doi-asserted-by":"publisher","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","volume":"88","author":"MJ Roger","year":"2000","unstructured":"Roger MJ, Gordon S, Benford HL, et al. Cellular and molecular mechanisms of action of bisphosphonates. Cancer. 2000;88(Suppl 12):2961\u201378.","journal-title":"Cancer"},{"key":"78_CR2","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1093\/rheumatology\/34.10.993","volume":"34","author":"F Liot\u00e9","year":"1995","unstructured":"Liot\u00e9 F, Boval-Boizard B, Fritz P, Kuntz D. Lymphocyte subsets in pamidronate-induced lymphopenia. Br J Rheumatol. 1995;34:993\u20135.","journal-title":"Br J Rheumatol"},{"key":"78_CR3","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1093\/annonc\/mdj105","volume":"17","author":"T Tanvetyanon","year":"2006","unstructured":"Tanvetyanon T, Stiff PJ. Management of the adverse effects associated with intravenous bisphosphonates. Ann Oncol. 2006;17:897\u2013907.","journal-title":"Ann Oncol"},{"key":"78_CR4","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1681\/ASN.V1261164","volume":"12","author":"GS Markowitz","year":"2001","unstructured":"Markowitz GS, Appel GB, Fine PL, Fenves AZ, Loon NR, Jagannath S, et al. Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol. 2001;12:1164\u201372.","journal-title":"J Am Soc Nephrol"},{"key":"78_CR5","doi-asserted-by":"publisher","first-page":"1856","DOI":"10.1093\/ndt\/17.10.1856-a","volume":"17","author":"JD Stratton","year":"2002","unstructured":"Stratton JD, Warwicker P. Relapse of nephrotic syndrome triggered by bisphosphonates. Nephrol Dial Transplant. 2002;17:1856\u20137.","journal-title":"Nephrol Dial Transplant"},{"key":"78_CR6","doi-asserted-by":"publisher","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","volume":"296","author":"DM Black","year":"2006","unstructured":"Black DM, Schwartz AV, Ensrud KE, Cauley JA, Levis S, Quandt SA, et al. Effects of continuing or stopping alendronate after 5\u00a0years of treatment. The fracture intervention trial long-term extension (FLEX): A randomized trial. JAMA. 2006;296:2927\u201338.","journal-title":"JAMA"},{"key":"78_CR7","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1056\/NEJMoa053569","volume":"355","author":"RNJ Nijs de","year":"2006","unstructured":"de Nijs RNJ, Jacobs JW, Lems WF, Laan RF, Algra A, Huisman AM, et al. Alendronate or alfacalcidol in glucocorticoid-induced osteoporosis. N Engl J Med. 2006;355:675\u201384.","journal-title":"N Engl J Med"},{"key":"78_CR8","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1111\/j.1523-1755.2005.00568.x","volume":"68","author":"H Dijkman","year":"2005","unstructured":"Dijkman H, Smeets B, van der Laak J, Steenbergen E, Wetzels J. The parietal epithelial cell is crucially involved in human idiopathic focal segmental glomerulosclerosis. Kidney Int. 2005;68:1562\u201372.","journal-title":"Kidney Int"},{"key":"78_CR9","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1681\/ASN.2004121134","volume":"16","author":"T Asano","year":"2005","unstructured":"Asano T, Niimura F, Pastan I, Fogo AB, Ichikawa I, Matsusaka T. Permanent genetic tagging of podocytes: Fate of injured podocytes in a mouse model of glomerular sclerosis. J Am Soc Nephrol. 2005;16:2257\u201362.","journal-title":"J Am Soc Nephrol"},{"key":"78_CR10","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1159\/000088400","volume":"102","author":"CB Marshall","year":"2006","unstructured":"Marshall CB, Shankland SJ. Cell cycle and glomerular disease: A minireview. Nephron Exp Nephrol. 2006;102:e39\u201348.","journal-title":"Nephron Exp Nephrol"},{"key":"78_CR11","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00198-007-0361-9","volume":"18","author":"J Pascual","year":"2007","unstructured":"Pascual J, Torrealba J, Myers J, Tome S, Samaniego M, Musat A, et al. Collapsing focal segmental glomerulosclerosis in a liver transplant recipient on alendronate. Osteoporos Int. 2007;18:1435\u20138.","journal-title":"Osteoporos Int"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-008-0078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-008-0078-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-008-0078-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-008-0078-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T14:05:30Z","timestamp":1631714730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-008-0078-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["78"],"URL":"https:\/\/doi.org\/10.1007\/s10157-008-0078-x","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}